Who
Kaitlin M. Kestenberg-Messina
COO and SVP, Compliance
Company insider
Files Form 4 as: COO and SVP, Compliance, ADMA Biologics.
In numbers
- Trades disclosed
- 67
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $724K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2024
- Last trade
- 24 Jul 2026
- Last filed
- 28 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jul 2026filed 28 Jul 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $27K3,177 at $8.37 | filing |
| 24 Jul 2026filed 28 Jul 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $27K3,177 at $8.37 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $185K20,362 at $9.11 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $185K20,362 at $9.11 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,250 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,646 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,525 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,175 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code J | —91,266 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,250 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,646 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,525 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,175 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $13K2,500 at $5.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $5,3881,250 at $4.31 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $7,4882,646 at $2.83 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $3,5841,525 at $2.35 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $3,3712,175 at $1.55 | filing |
News
Arcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head SurveyADMA · dailypolitical.com · 18 Oct 2026Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Kaitlin M. Kestenberg-Messina; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.